Business & Finance
Business and Finance
Business and Finance
Wed, October 6, 2010
Tue, October 5, 2010 EQT Corporation, Martin Midstream Partners L.P., The Procter & Gamble Companyand Ardea Biosciences
CHICAGO--([ BUSINESS WIRE ])--Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List a" Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): EQT Corporation (NYSE: [ EQT ])and Martin Midstream Partners L.P. (Nasdaq: [ MMLP ]) Further, Zacks announced #4 Rankings (Sell) on two other widely held stocks: The Procter & Gamble Company (NYSE: [ PG ])and Ardea Biosciences, Inc. (Nasdaq: [ RDEA ]) To see the full Zacks #5 Rank List - Stocks to Sell Now visit: [ http://at.zacks.com/?id=92 ]
"Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions"
Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.
Here is a synopsis of why EQT and MMLP have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe:
EQT Corporationa™s (NYSE: [ EQT ]) second quarter earnings of 20 cents per share which was announced on July 29, lagged analysts expectations by 5 cents. The Zacks Consensus Estimate for the current year slid 10 cents to $ 1.56 per share over the past month as 8 out of the 12 covering analysts lowered projections. The following yeara™s forecast dropped 91 cents to $ 1.89 per share in the same period.
Martin Midstream Partners L.P. (Nasdaq: [ MMLP ]) second quarter earnings of 13 cents per share, announced on August 4, trailed the Zacks Consensus Estimate by 26 cents. The last 60 days has seen downward revision by the covering analysts, bringing the full-year average forecast down 41 cents to 78 cents per share. The forecast for the next year also dipped 23 cents to $ 1.25 in the same time period.
Here is a synopsis of why PG and RDEA have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;
The Procter & Gamble Company(NYSE: [ PG ]) posted fourth - quarter earnings of 71 cents per share on August 3, which was 3 cent below estimates. The Zacks Consensus Estimate for the full year declined 2 cents to a profit of $ 3.96 in the past 90 days. Next yeara™s forecast slipped 4 cents to a profit of $ 4.33 in that time period.
Ardea Biosciences, Inc. (Nasdaq: [ RDEA ])posted second quarter loss of 57 cents per share on August 6, which was 11 cents worse than the average fore cast. Revenues slid 36 % $ 3.52 million. For the full year the Zacks Consensus Estimate widened to a loss of 3 cents per share to $ 2.06 in the past one month, reflecting downward revisions by the covering analysts. During that time next yeara™s estimate declined 5 cents to a loss of $ 1.69 per share.
Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report; aZacks Rank Guide: Harnessing the Power of Earnings Estimate Revisionsa is available to provide this insightful background. Download a free copy now to prosper in the years to come at [ http://at.zacks.com/?id=93 ]
About the Zacks Rank
Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank Stocks have generated an average annual return of +27%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (-0.9% versus +9%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.
Visit [ http://www.zacks.com/performance ] for information about the performance numbers displayed in this press release.
Zacks aProfit from the Prosa e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting [ http://at.zacks.com/?id=94 ]
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at [ http://at.zacks.com/?id=95 ]
Follow us on Twitter: [ http://twitter.com/zacksresearch ]
Join us on Facebook: [ http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts ]
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
